CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 105 filers reported holding CLOVIS ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | +20.0% | 10,183 | +80.5% | 0.00% | – |
| Q2 2022 | $10,000 | -92.9% | 5,640 | -91.9% | 0.00% | – |
| Q1 2022 | $141,000 | -7.8% | 69,772 | +23.8% | 0.00% | – |
| Q4 2021 | $153,000 | -33.2% | 56,359 | +9.5% | 0.00% | – |
| Q3 2021 | $229,000 | -10.9% | 51,446 | +16.2% | 0.00% | – |
| Q2 2021 | $257,000 | -79.0% | 44,255 | -74.6% | 0.00% | – |
| Q1 2021 | $1,221,000 | +17.3% | 173,891 | -19.9% | 0.00% | – |
| Q4 2020 | $1,041,000 | -29.8% | 217,137 | -13.0% | 0.00% | – |
| Q3 2020 | $1,482,000 | -18.2% | 249,536 | -7.0% | 0.00% | – |
| Q2 2020 | $1,811,000 | -14.5% | 268,177 | -19.5% | 0.00% | – |
| Q1 2020 | $2,117,000 | -52.4% | 332,971 | -21.8% | 0.00% | -100.0% |
| Q4 2019 | $4,443,000 | +385.6% | 426,043 | +83.1% | 0.00% | – |
| Q3 2019 | $915,000 | -80.1% | 232,643 | -31.6% | 0.00% | -100.0% |
| Q2 2019 | $4,595,000 | -10.9% | 339,887 | +63.6% | 0.00% | 0.0% |
| Q1 2019 | $5,155,000 | +82.9% | 207,704 | +32.3% | 0.00% | 0.0% |
| Q4 2018 | $2,819,000 | -79.9% | 156,942 | -67.1% | 0.00% | -66.7% |
| Q3 2018 | $13,994,000 | +26.4% | 476,491 | +95.7% | 0.00% | +50.0% |
| Q2 2018 | $11,071,000 | -3.8% | 243,488 | +11.7% | 0.00% | 0.0% |
| Q1 2018 | $11,514,000 | +1.1% | 218,081 | +30.3% | 0.00% | 0.0% |
| Q4 2017 | $11,385,000 | +105.6% | 167,417 | +142.1% | 0.00% | +100.0% |
| Q3 2017 | $5,538,000 | +36.8% | 69,146 | +60.0% | 0.00% | 0.0% |
| Q2 2017 | $4,047,000 | -60.9% | 43,215 | -73.4% | 0.00% | -50.0% |
| Q1 2017 | $10,361,000 | +36.9% | 162,741 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $7,569,000 | +17.9% | 170,388 | -4.4% | 0.00% | 0.0% |
| Q3 2016 | $6,421,000 | +490.2% | 178,137 | +124.6% | 0.00% | – |
| Q2 2016 | $1,088,000 | -73.8% | 79,299 | -63.4% | 0.00% | -100.0% |
| Q1 2016 | $4,157,000 | -33.8% | 216,585 | +20.8% | 0.00% | -50.0% |
| Q4 2015 | $6,277,000 | -56.9% | 179,342 | +13.3% | 0.00% | -50.0% |
| Q3 2015 | $14,553,000 | -16.1% | 158,264 | -19.8% | 0.00% | 0.0% |
| Q2 2015 | $17,339,000 | +21.0% | 197,300 | +2.2% | 0.00% | +33.3% |
| Q1 2015 | $14,332,000 | +48.3% | 193,065 | +11.8% | 0.00% | +50.0% |
| Q4 2014 | $9,666,000 | +920.7% | 172,622 | +726.8% | 0.00% | – |
| Q3 2014 | $947,000 | -23.3% | 20,878 | -29.9% | 0.00% | – |
| Q2 2014 | $1,235,000 | -83.6% | 29,787 | -72.6% | 0.00% | -100.0% |
| Q1 2014 | $7,532,000 | +83.7% | 108,739 | +59.8% | 0.00% | +100.0% |
| Q4 2013 | $4,101,000 | -14.5% | 68,026 | -13.8% | 0.00% | 0.0% |
| Q3 2013 | $4,799,000 | -39.6% | 78,934 | -33.4% | 0.00% | -66.7% |
| Q2 2013 | $7,939,000 | – | 118,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |